GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and increased reelin proteins in the hippocampus

Brain Research

Volumn 1334, Issue , 2010, Pages 12-24

  Wierońska, Joanna M ^a   Branski P ^a   Siwek, A ^b   Dybala, M ^b   Nowak, G ^a,b   Pilc, A ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

GABA; GABAB; GAD; Metabotropic glutamate receptors; Reelin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMIC ACID; MESSENGER RNA; METABOTROPIC RECEPTOR 7; REELIN;

AMINO ACID SYNTHESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

ANALYSIS OF VARIANCE; ANIMALS; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX PROTEINS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; ORGANOPHOSPHORUS COMPOUNDS; PROTEIN BINDING; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TRITIUM;

ANIMALIA; MUS;

EID: 77952109021     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.078     Document Type: Article

References (77)

1. 3H]CGP54626 to GABAB receptors in the male bullfrog (Rana catesbeiana). Brain Res. 1094 1 (2006) 76-85
2. Berrettini W.H., Nurnberger Jr. J.I., Hare T.A., Simmons-Alling S., Gershon E.S., and Post R.M. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol. Psychiatry 18 (1983) 185-194
3. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., and Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am. J. Psychiatry 161 2 (2004) 368-370
4. Birnstiel S., and Haas H.L. Acute effects of antidepressant drugs on long-term potentiation (LTP) in rat hippocampal slices. Naunyn Schmiedebergs Arch. Pharmacol. 344 1 (1991) 79-83
5. B receptors. Pharmacol. Commun. 2 (1992) 23
6. Brambilla P., Perez J., Barale F., Schettini G., and Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 8 721-37 (2003) 715
7. Carlsson A., and Carlsson M.L. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues Clin. Neurosci. 8 1 (2006) 137-142
8. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., and Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 8 (2001) 723-742
9. Costa E., Davis J., Pesold C., Tueting P., and Guidotti A. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr. Opin. Pharmacol. 2 (2002) 56-62
10. Cryan J.F., and Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol. Psychiatry 9 (2004) 326-357
11. Cryan J.F., Kelly P.H., Neijt H.C., Sansig G., Flor P.J., and van der Putten H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur. J. Neurosci. 17 (2003) 2409-2417
12. Cryan J.F., Mombereau C., and Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 29 4-5 (2005) 571-625
13. Dong E., Caruncho H., Liu W.S., Smalheiser N.R., Grayson D.R., Costa E., and Guidotti A. A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes. Proc. Natl. Acad. Sci USA 100 9 (2003) 5479-5484
14. Erlander M.G., and Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem. Res. 16 (1991) 215-226
15. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., and Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 7 (1991) 91-100
16. Fatemi S.H., Earle J.A., and McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 5 6 (2000) 654-663 (571)
17. Fatemi S.H., Kroll J.L., and Stary J.M. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 12 15 (2001) 3209-3215 (29)
18. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., and Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr. Res. 72 (2005) 109-122
19. Feldblum S., Erlander M.G., and Tobin A.J. Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J. Neurosci. Res. 34 (1993) 689-706
20. Flor P.J., van der Putten H., Ruegg D., Lukic S., Leonhardt T., Bence M., Sansig G., Knopfel T., and Kuhn R. A novel splice variant of a metabotropic glutamate receptor, human mGluR7b. Neuropharmacology 36 (1997) 153-159
21. Fukuda T., Heizmann C.W., and Kosaka T. Quantitative analysis of GAD65 and GAD67 immunoreactivities in somata of GABAergic neurons in the mouse hippocampus proper (CA1 and CA3 regions), with special reference to parvalbumin-containing neurons. Brain Res. 764 (1997) 237-243
22. Gierdalski M., Jablonska B., Smith A., Skangiel-Kramska J., and Kossut M. Deafferentation induced changes in GAD67 and GluR2 mRNA expression in mouse somatosensory cortex. Brain Res. Mol. Brain Res. 71 (1999) 111-119
23. Gierdalski M., Jablonska B., Siucinska E., Lech M., Skibinska A., and Kossut M. Rapid regulation of GAD67 mRNA and protein level in cortical neurons after sensory learning. Cereb. Cortex 11 (2001) 806-815
24. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57 (2000) 65-73
25. Goddard A.W., Mason G.F., Appel M., Rothman D.L., Gueorguieva R., Behar K.L., and Krystal J.H. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am. J. Psychiatry 161 (2004) 2186-2193
26. Grant S.G., Karl K.A., Kiebler M.A., and Kandel E.R. Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev. 9 15 (1995) 1909-1921
27. Guidotti A., Auta J., Davis J.M., Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., and Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57 (2000) 1061-1069
28. Guidotti A., Auta J., Davis J.M., Dong E., Grayson D.R., Vieldic M., Zhang X., and Costa E. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology 180 2 (2005) 191-205
29. Gundersen H.J., and Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147 (1987) 229-263
30. Heckers S., Stone D., Walsh J., Shick J., Koul P., and Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59 (2002) 521-529
31. Herman J.P., and Larson B.R. Differential regulation of forebrain glutamic acid decarboxylase mRNA expression by aging and stress. Brain Res. 912 (2001) 60-66
32. Holderbach R., Clark K., Moreau J.L., Bischofberger J., and Normann C. Enhanced long-term synaptic depression in an animal model of depression. Biol. Psychiatry 62 1 (2007) 92-100
33. Ishikawa M., Mizukami K., Iwakiri M., and Asada T. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci. Lett. 383 (2005) 272-277
34. Javitt D.C. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J. Clin. Psychiatry 9 1 (1987) 12-35
35. Kaiya H., Namba M., Yoshida H., and Nakamura S. Plasma glutamate decarboxylase activity in neuropsychiatry. Psychiatry Res. 6 (1982) 335-343
36. Kaufman D.L., McGinnis J.F., Krieger N.R., and Tobin A.J. Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces gamma-aminobutyric acid. Science 232 (1986) 1138-1140
37. Kinoshita A., Shigemoto R., Ohishi H., van der Putten H., and Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J. Comp. Neurol. 393 (1998) 332-352
38. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., Epperson C.N., Goddard A., and Mason G.F. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 7 Suppl 1 (2002) S71-S80
39. Kulik A., Vida I., Lujan R., Haas C.A., Lopez-Bendito G., Shigemoto R., and Frotscher M. Subcellular localization of metabotropic GABA(B) receptor subunits GABA(B1a/b) and GABA(B2) in the rat hippocampus. J. Neurosci. 23 (2003) 11026-11035
40. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
41. Laprade N., and Soghomonian J.J. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse 33 (1999) 36-48
42. Lavreysen H., and Dautzenberg F.M. Therapeutic potential of group III metabotropic glutamate receptors. Curr. Med. Chem. 15 (2008) 671-684
43. Li X., Gardner E.L., and Xi Z.X. The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats. Neuropharmacology 54 3 (2008) 542-551
44. Liu W.S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lacor P., Larson J., Condie B.G., Guidotti A., and Costa E. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc. Natl. Acad. Sci. USA 98 (2001) 3477-3482
45. Makoff A., Pilling C., Harrington K., and Emson P. Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS. Brain Res. Mol. Brain Res. 40 (1996) 165-170
46. Martin D.L., and Barke K.E. Are GAD65 and GAD67 associated with specific pools of GABA in brain?. Perspect. Dev. Neurobiol. 5 (1998) 119-129
47. Martin D.L., and Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J. Neurochem. 60 (1993) 395-407
48. Masugi M., Yokoi M., Shigemoto R., Muguruma K., Watanabe Y., Sansig G., van der Putten H., and Nakanishi S. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. J. Neurosci. 19 3 (1999) 955-963
49. Mitsukawa K., Mombereau C., Lotscher E., Uzunov D.P., van der Putten H., Flor P.J., and Cryan J.F. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: mplications for stress-related psychiatric disorders. Neuropsychopharmacology 31 (2006) 1112-1122
50. Mizukami K., Sasaki M., Ishikawa M., Iwakiri M., Hidaka S., Shiraishi H., and Iritani S. Immunohistochemical localization of gamma-aminobutyric acid(B) receptor in the hippocampus of subjects with schizophrenia. Neurosci. Lett. 283 (2000) 101-104
51. Mizukami K., Ishikawa M., Hidaka S., Iwakiri M., Sasaki M., and Iritani S. Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 393-396
52. Mombereau C., Kaupmann K., van der Putten H., and Cryan J.F. Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors. Eur. J. Pharmacol. 497 1 (2004) 119-120
53. B receptor antagonists, in rodents. Br. J. Pharmacol. 149 (2006) 581-590
54. Ossowska K., Wardas J., Smialowska M., Kuter K., Lenda T., Wieronska J.M., Zieba B., Nowak P., Dabrowska J., Bortel A., Kwiecinski A., and Wolfarth S. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?. Eur. J. Neurosci. 22 (2005) 1294-1304
55. Ossowska K., Smialowska M., Kuter K., Wieronska J., Zieba B., Wardas J., Nowak P., Dabrowska J., Bortel A., Biedka I., Schulze G., and Rommelspacher H. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease. Neuroscience 141 (2006) 2155-2165
56. Palazzo E., Fu Y., Ji G., Maione S., and Neugebauer V. Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors. Neuropharmacology 55 4 (2008) 537-545
57. Palucha A., and Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol. Ther. 115 (2007) 116-147
58. Palucha A., Klak K., Branski P., van der Putten H., Flor P.J., and Pilc A. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Psychopharmacology (Berl.) (2007)
59. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed (1986), Academic Press Inc, San Diego, CA
60. Pesold C., Impagnatiello F., Pisu M.G., Uzunov D.P., Costa E., Guidotti A., and Caruncho H.J. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc. Natl. Acad. Sci. USA 95 6 (1998) 3221-3226
61. Pilc A., and Lloyd K.G. Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. Life Sci. 35 (1984) 2149-2154
62. Pilc A., and Nowak G. GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs Today (Barc.) 41 (2005) 755-766
63. Pin J.P., and Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995) 1-26
64. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., and Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32 2 (2007) 471-482
65. Rice D.S., and Curran T. Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci. 24 (2001) 1005-1039
66. Rosoklija G., Toomayan G., Ellis S.P., Keilp J., Mann J.J., Latov N., Hays A.P., and Dwork A.J. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch. Gen. Psychiatry 57 (2000) 349-356
67. Sanacora G., Mason G.F., Rothman D.L., and Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry 159 (2002) 663-665
68. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., Krystal J.H., and Mason G.F. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 61 (2004) 705-713
69. Sansig G., Bushell T.J., Clarke V.R., Rozov A., Burnashev N., Portet C., Gasparini F., Schmutz M., Klebs K., Shigemoto R., Flor P.J., Kuhn R., Knoepfel T., Schroeder M., Hampson D.R., Collett V.J., Zhang C., Duvoisin R.M., Collingridge G.L., and van der Putten H. Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7. J. Neurosci. 21 (2001) 8734-8745
70. Scotti A.L., and Herrmann G. Reelin immunoreactivity in dissociated cultures of the postnatal hippocampus. Brain Res. 924 2 (2002) 209-218
71. Somogyi P., Dalezios Y., Luján R., Roberts J.D., Watanabe M., and Shigemoto R. High level of mGluR7 in the presynaptic active zones of select populations of GABAergic terminals innervating interneurons in the rat hippocampus. Eur. J. Neurosci. 17 12 (2003) 2503-2520
72. Stachowicz K., Branski P., Klak K., van der Putten H., Cryan J.F., Flor P.J., and Andrzej P. Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission. Behav. Pharmacol. 19 (2008) 597-603
73. Sterio D.C. The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134 (1984) 127-136
74. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., and Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57 (2000) 237-245
75. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., and Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277 42 (2002) 39944-39952 Oct 18
76. Wierońska J.M., Śmialowska M., Brański P., Gasparini F., Kłodzińska A., Szewczyk B., Pałucha A., Chojnacka-Wójcik E., and Pilc A. In the amygdala anxiolytic action of mGlu5 receptor antagonist MPEP involves neuropeptide Y but not GABAA signalling. Neuropsychopharmacology 29 3 (2004) 514-521
77. Wieronska J.M., and Pilc A. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochem. Int. 55 (2009) 85-97